41
Participants
Start Date
June 4, 2021
Primary Completion Date
September 27, 2022
Study Completion Date
September 27, 2022
Levcromakalim
12 active episodic patients, 15 episodic patients in remission and 20 chronic patients of both genders are randomized to receive a 20-minute infusion of levcromakalim and/or sterile saline on two days, with at least 3 days in between.
Saline
12 active episodic patients, 15 episodic patients in remission and 20 chronic patients of both genders are randomized to receive a 20-minute infusion of levcromakalim and/or sterile saline on two days, with at least 3 days in between.
Danish Headache Center, Glostrup Municipality
Danish Headache Center
OTHER